Search

Taghi Manshouri

from Houston, TX
Age ~66

Taghi Manshouri Phones & Addresses

  • 7705 Valley View Ln, Houston, TX 77074 (713) 777-3713
  • 8217 Sands Point Dr, Houston, TX 77036
  • Bellaire, TX

Publications

Us Patents

Measuring Circulating Therapeutic Antibody, Antigen And Antigen/antibody Complexes Using Elisa Assays

View page
US Patent:
7943332, May 17, 2011
Filed:
Apr 16, 2010
Appl. No.:
12/761903
Inventors:
Maher Albitar - Sugarland TX,
Michael J. Keating - Houston TX,
Taghi Manshouri - Houston TX,
Assignee:
Board of Regents, the University of Texas System - Austin TX
International Classification:
G01N 31/00
G01N 33/53
US Classification:
435 721, 435 71, 436 1, 436501, 436518, 424 91, 424520, 422 1, 422 50, 530300, 530350
Abstract:
The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

Measuring Circulating Therapeutic Antibody, Antigen And Antigen/antibody Complexes Using Elisa Assays

View page
US Patent:
8114618, Feb 14, 2012
Filed:
Apr 5, 2011
Appl. No.:
13/080180
Inventors:
Maher Albitar - Sugarland TX,
Michael J. Keating - Houston TX,
Taghi Manshouri - Houston TX,
Assignee:
Board of Regents of the University of Texas System - Austin TX
International Classification:
G01N 31/00
US Classification:
435 721, 435 4, 435 71, 4352879, 436501, 436518, 436525, 436529, 436535, 436809, 427287, 427337, 427338, 530300, 530350
Abstract:
The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

Measuring Circulating Therapeutic Antibody, Antigen And Antigen/antibody Complexes Using Elisa Assays

View page
US Patent:
8232068, Jul 31, 2012
Filed:
Jan 12, 2012
Appl. No.:
13/349170
Inventors:
Maher Albitar - Sugarland TX,
Michael J. Keating - Houston TX,
Taghi Manshouri - Houston TX,
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 31/00
G01N 33/53
US Classification:
435 721, 435 4, 435 71, 4352879, 436501, 436518, 436525, 436529, 436535, 436809, 427287, 427337, 427338, 530300, 530350
Abstract:
The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

Measuring Circulating Therapeutic Antibody, Antigen And Antigen/antibody Complexes Using Elisa Assays

View page
US Patent:
8501423, Aug 6, 2013
Filed:
Jul 6, 2012
Appl. No.:
13/543560
Inventors:
Maher Albitar - Sugar Land TX,
Michael J. Keating - Houston TX,
Taghi Manshouri - Houston TX,
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 31/00
G01N 33/53
US Classification:
435 721, 435 4, 435 71, 4352879, 436501, 436518, 427287, 427337, 427338, 530300, 530350
Abstract:
The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

Measuring Circulating Therapeutic Antibody, Antigen And Antigen/antibody Complexes Using Elisa Assays

View page
US Patent:
2003006, Apr 10, 2003
Filed:
Sep 20, 2002
Appl. No.:
10/251144
Inventors:
Maher Albitar - Sugarland TX,
Michael Keating - Houston TX,
Taghi Manshouri - Houston TX,
Assignee:
Board of Regents, The University of Texas System
International Classification:
G01N033/53
G01N033/537
G01N033/543
US Classification:
435/007920
Abstract:
The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

Measuring Circulating Therapeutic Antibody, Antigen And Antigen/antibody Complexes Using Elisa Assays

View page
US Patent:
2014001, Jan 9, 2014
Filed:
Jul 3, 2013
Appl. No.:
13/934940
Inventors:
Michael J. KEATING - Houston TX,
Taghi MANSHOURI - Houston TX,
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 33/68
US Classification:
435 723, 435 792, 435 79
Abstract:
The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.
Taghi Manshouri from Houston, TX, age ~66 Get Report